Cancer Rates in Young Children are Increasing Worldwide

									Charlie Plain |
																			April 22, 2019

Rates of pediatric cancer have been rising since the 1980s; however, this increase varies by age group and cancer type. A research team led by School of Public Health PhD student Aubrey Hubbard studied children under five years of age to understand cancer trends that occur in this age group around the world. The findings were recently published in the journal JNCI Cancer Spectrum.

Aubrey Hubbard smiling.
PhD student Aubrey Hubbard

The International Agency for Research on Cancer, which is part of the World Health Organization, collects detailed information on the number of cancer cases that occur globally in children and adults. The researchers analyzed data from individual countries in 15 subregional categories to compare trends in cancer rates for 11 different types of pediatric cancer from 1988 to 2012.

The study found:

  • in children under five years of age, cancer rates increased for both common types of childhood leukemia, one brain tumor subtype, neuroblastoma and hepatoblastoma;
  • hepatoblastoma, a rare liver tumor, had the largest increase in incidence in 11 out of 15 regions (the increases ranged from 1.9-6.5 percent per year);
  • hepatoblastoma incidence increased in all regions except southern Asia;
  • astrocytic tumors in the brain were the only cancer that decreased over the time period.

“We observed small but significant increases in the rates of several types of childhood cancer in developed countries,” says Hubbard.

“While our research suggests hepatoblastoma is the fastest rising cancer in children under five, this is still a very rare cancer. This finding should not be concerning to parents,” says study co-author Jenny Poynter, an associate professor in the Medical School and Masonic Cancer Center member. “While we attempted to evaluate rates for all regions in the world, the data are too sparse to say if this pattern exists in less developed countries.”

Further research is needed to understand the causes of hepatoblastoma.

© 2015 Regents of the University of Minnesota. All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Privacy Statement